Potential bias in ophthalmic pharmaceutical clinical trials

Paul VarnerJohn J Pershing Veterans&rsquo; Administration Medical Center, Poplar Bluff, Missouri, USAAbstract: To make clinicians aware of potential sources of error in ophthalmic pharmaceutical clinical trials that can lead to erroneous interpretation of results, a critical review of the st...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Paul Varner
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/12c8bb65eba64033ac521bbd993f403b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:12c8bb65eba64033ac521bbd993f403b
record_format	dspace
spelling	oai:doaj.org-article:12c8bb65eba64033ac521bbd993f403b2021-12-02T00:59:41ZPotential bias in ophthalmic pharmaceutical clinical trials1177-54671177-5483https://doaj.org/article/12c8bb65eba64033ac521bbd993f403b2008-06-01T00:00:00Zhttp://www.dovepress.com/potential-bias-in-ophthalmic-pharmaceutical-clinical-trials-a1795https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Paul VarnerJohn J Pershing Veterans&rsquo; Administration Medical Center, Poplar Bluff, Missouri, USAAbstract: To make clinicians aware of potential sources of error in ophthalmic pharmaceutical clinical trials that can lead to erroneous interpretation of results, a critical review of the study design of various pharmaceutical ophthalmic clinical trials was completed. Discrepancies as a result of study shortcomings may explain observed differences between reported ophthalmic trial data and observed clinical results.Keywords: evidence-based medicine, validity, bias, gold standard Paul VarnerDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2008, Iss Issue 2, Pp 401-411 (2008)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Paul Varner Potential bias in ophthalmic pharmaceutical clinical trials
description	Paul VarnerJohn J Pershing Veterans&rsquo; Administration Medical Center, Poplar Bluff, Missouri, USAAbstract: To make clinicians aware of potential sources of error in ophthalmic pharmaceutical clinical trials that can lead to erroneous interpretation of results, a critical review of the study design of various pharmaceutical ophthalmic clinical trials was completed. Discrepancies as a result of study shortcomings may explain observed differences between reported ophthalmic trial data and observed clinical results.Keywords: evidence-based medicine, validity, bias, gold standard
format	article
author	Paul Varner
author_facet	Paul Varner
author_sort	Paul Varner
title	Potential bias in ophthalmic pharmaceutical clinical trials
title_short	Potential bias in ophthalmic pharmaceutical clinical trials
title_full	Potential bias in ophthalmic pharmaceutical clinical trials
title_fullStr	Potential bias in ophthalmic pharmaceutical clinical trials
title_full_unstemmed	Potential bias in ophthalmic pharmaceutical clinical trials
title_sort	potential bias in ophthalmic pharmaceutical clinical trials
publisher	Dove Medical Press
publishDate	2008
url	https://doaj.org/article/12c8bb65eba64033ac521bbd993f403b
work_keys_str_mv	AT paulvarner potentialbiasinophthalmicpharmaceuticalclinicaltrials
_version_	1718403363624714240

Potential bias in ophthalmic pharmaceutical clinical trials

Ejemplares similares